Published in Br J Clin Pharmacol on December 01, 1999
Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology (2009) 1.19
Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients. J Res Med Sci (2014) 1.01
Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J (2005) 0.96
Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br J Pharmacol (2001) 0.94
Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective. Int J Appl Basic Med Res (2011) 0.91
Cutaneous adverse drug reactions in Indian population: A systematic review. Indian Dermatol Online J (2014) 0.88
UV-Vis spectrophotometrical and analytical methodology for the determination of singlet oxygen in new antibacterials drugs. Anal Chem Insights (2007) 0.82
A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India. Indian Dermatol Online J (2015) 0.78
Piroxicam-β-cyclodextrin: a GI safer piroxicam. Curr Med Chem (2013) 0.77
Use and safety profile of antiepileptic drugs in Italy. Eur J Clin Pharmacol (2007) 0.75
A pilot study on the incidence of severe photosensitivity reactions leading to hospitalization linked to topical ketoprofen and other medications in selected European regions. Pharmacol Res Perspect (2016) 0.75
Morphological Pattern of Cutaneous Adverse Drug Reactions due to Antiepileptic Drugs in Eastern India. J Clin Diagn Res (2015) 0.75
Retrospective Analysis of Pattern of Cutaneous Adverse Drug Reactions in Tertiary Hospital of Pauri Garhwal. J Clin Diagn Res (2016) 0.75
Severe adverse cutaneous reactions to drugs. N Engl J Med (1994) 8.47
Computerized surveillance of adverse drug events in hospital patients. JAMA (1991) 8.21
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med (1995) 7.21
Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol (1993) 5.51
Pharmaceutical prescriptions in four European countries. Lancet (1993) 4.09
Adverse reactions to co-trimoxazole in HIV infection. Lancet (1991) 3.16
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol (1995) 2.16
Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA (1988) 2.13
Review of yellow cards--1986 and 1987. Br Med J (Clin Res Ed) (1988) 1.81
Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status. Pharmacol Toxicol (1991) 1.81
Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc (1991) 1.80
Rash with amoxycillin-clavulanate therapy in HIV-infected patients. Lancet (1989) 1.47
Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA (1986) 1.45
Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol (1997) 1.31
Principles of signal detection in pharmacovigilance. Drug Saf (1997) 1.31
The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts. Drug Saf (1998) 1.25
Cutaneous reactions to alimentary tract medications: results of a seven-year surveillance program and review of the literature. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Dermatology (1996) 1.11
Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations. Eur J Clin Pharmacol (1994) 1.09
National adverse drug reaction surveillance: 1985. JAMA (1987) 1.08
Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy (1997) 1.06
A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection. Urology (1998) 1.02
Fluoroquinolone toxicities. An update. Drugs (1995) 1.01
[French pharmacovigilance database system: examples of utilisation]. Therapie (1996) 1.01
Skin reactions to antibacterial agents in general practice. J Clin Epidemiol (1998) 1.00
An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol (1995) 0.99
The Erice declaration: on communicating drug safety information. Prescrire Int (1998) 0.99
Phototoxic potential of quinolone antibacterial agents in Balb/c mice. Toxicol Lett (1990) 0.94
Cutaneous adverse reactions associated with calcium channel blockers. Arch Intern Med (1989) 0.94
Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia. Dermatology (1993) 0.91
Ampicillin sensitivity in infectious mononucleosis--temporary or permanent? Scand J Infect Dis (1972) 0.84
The impact of age on risk of adverse drug reactions to digoxin. For The Gruppo Italiano di Farmacovigilanza nell' Anziano. J Clin Epidemiol (1993) 0.83
Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol (1990) 0.82
Photosensitizing potential of ofloxacin. Int J Dermatol (1993) 0.82
Photoreactions with a fluoroquinolone antimicrobial: evening versus morning dosing. Clin Pharmacol Ther (1994) 0.81
Drug rashes. What are the targets of cell-mediated cytotoxicity? Arch Dermatol (1994) 0.81
Adverse drug reactions leading to hospital admission. Drug Saf (1992) 0.80
Age and severe adverse drug reactions caused by nifedipine and verapamil. Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA). J Clin Epidemiol (1996) 0.79
Dipyrone as a cause of drug rashes: an epidemiologic study. Int J Epidemiol (1973) 0.77
Communicating drug-safety information. Lancet (1997) 0.77
[Spontaneous reports on unwanted drug effects in the years 1978-1979]. Fortschr Med (1981) 0.77
Identifying adverse reactions to drugs. Reporting systems. Clin Dermatol (1990) 0.77
A comparative study of adverse drug reactions reported through hospital and private medicine. Br J Clin Pharmacol (1996) 0.76
Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med (1998) 2.32
Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol (1999) 2.08
Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe. Am J Epidemiol (1998) 1.65
Epidemiological impact of prolonged systematic use of topical SDD on bacterial colonization of the tracheobronchial tree and antibiotic resistance. A three year study. Intensive Care Med (1993) 1.53
Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Arch Dis Child Fetal Neonatal Ed (2005) 1.47
Calcium/calmodulin-dependent protein kinase II is associated with NR2A/B subunits of NMDA receptor in postsynaptic densities. J Neurochem (1998) 1.33
Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies. Agents Actions (1993) 1.11
Genetically altered AMPA-type glutamate receptor kinetics in interneurons disrupt long-range synchrony of gamma oscillation. Proc Natl Acad Sci U S A (2001) 1.11
Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther (2006) 1.04
Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database. J Clin Epidemiol (1999) 1.01
Prenatal methylazoxymethanol treatment in rats produces brain abnormalities with morphological similarities to human developmental brain dysgeneses. J Neuropathol Exp Neurol (1999) 0.98
Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy. Clin Cancer Res (1996) 0.97
A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system. Mol Pharmacol (1999) 0.96
Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med (1999) 0.96
Copper and ceruloplasmin (Cp) concentrations during the acute inflammatory process in the rat. Agents Actions (1982) 0.93
Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment. Clin Exp Rheumatol (1993) 0.93
Storage of a sensory pattern by anti-Hebbian synaptic plasticity in an electric fish. Proc Natl Acad Sci U S A (1993) 0.93
Concerning the role of endogenous copper in the acute inflammatory process. Agents Actions (1979) 0.93
Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area. Drug Saf (2001) 0.91
Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol (1999) 0.91
bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer. Clin Cancer Res (1998) 0.91
Copper and inflammation--a possible rationale for the pharmacological manipulation of inflammatory disorders. Agents Actions (1985) 0.89
Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol. Ann Oncol (1998) 0.89
Antimicrobial drug utilisation in hospitals in Italy and other European countries. Infection (1994) 0.88
Pharmacokinetics and human tissue penetration of flurithromycin. Antimicrob Agents Chemother (1988) 0.88
The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells. J Inorg Biochem (1999) 0.88
Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth (2002) 0.87
Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology). BMC Infect Dis (2012) 0.87
Extended vertical transseptal approach versus conventional left atriotomy for mitral valve surgery. J Heart Valve Dis (1999) 0.87
Antibiotic prescribing patterns in Italian hospital inpatients with pneumonia, chronic obstructive pulmonary disease, and urinary tract infections. Ann Pharmacother (1993) 0.86
Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen. Pharmacol Res (1995) 0.86
The electric image in Gnathonemus petersii. J Physiol Paris (2003) 0.85
gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney. Eur J Cancer (2003) 0.85
Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Pharmacopsychiatry (2001) 0.85
Copper and zinc status in adjuvant-arthritic rat: studies on blood, liver, kidneys, spleen and inflamed paws. Agents Actions (1988) 0.85
Structural and functional aspects of the fast electrosensory pathway in the electrosensory lateral line lobe of the pulse fish Gymnotus carapo. J Comp Neurol (1998) 0.85
Metabolic interaction between n-hexane and toluene in vivo and in vitro. Int Arch Occup Environ Health (1982) 0.85
Identification of severe potential drug-drug interactions using an Italian general-practitioner database. Eur J Clin Pharmacol (2007) 0.84
Coupled aggregation and sedimentation processes: the sticking probability effect. Phys Rev E Stat Nonlin Soft Matter Phys (2003) 0.84
Physiology and plasticity of morphologically identified cells in the mormyrid electrosensory lobe. J Neurosci (1997) 0.84
Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent. Am J Respir Crit Care Med (2001) 0.84
Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance. Biochem Pharmacol (1998) 0.84
Penetration of imipenem-cilastatin into the lung tissue and pericardial fluid of thoracotomized patients. Chemioterapia (1987) 0.83
Dual effects of a homeopathic mineral complex on carrageenan-induced oedema in rats. Br Homeopath J (1999) 0.83
Active infective endocarditis in infants and childhood: ten-year review of surgical therapy. J Card Surg (1998) 0.83
[Ultrastructural changes in the kidney in spontaneous diabetes in the Chinese hamster (Cricetulus griseus)]. Acta Diabetol Lat (1973) 0.83
Selective in vitro blockade of neuroepithelial cells proliferation by methylazoxymethanol, a molecule capable of inducing long lasting functional impairments. J Neurosci Res (1995) 0.82
A scientific reappraisal of the 'principle of similarity'. Med Hypotheses (1997) 0.82
Use of amoxicillin and amoxicillin-clavulanic acid and hospitalization for acute liver injury. Ann Ist Super Sanita (1999) 0.82
Parathormone, calcitonin, and vitamin D metabolites during normal fracture healing in geriatric patients. Clin Orthop Relat Res (1985) 0.82
Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors. Ther Drug Monit (1995) 0.81
Limbic epilepsy induced in the rat by dendrotoxin, a polypeptide isolated from the green mamba (Dendroaspis angusticeps) venom. Toxicon (1987) 0.81
Serum calcitonin and blood mineral interrelationships in normal children aged six to twelve years. Pediatr Res (1977) 0.81
Copper metabolism during acute inflammation: studies on liver and serum copper concentrations in normal and inflamed rats. Br J Pharmacol (1983) 0.81
Imipenem kinetics in serum, lung tissue and pericardial fluid in patients undergoing thoracotomy. J Antimicrob Chemother (1987) 0.81
[Homeopathy in the perspective of scientific research]. Ann Ist Super Sanita (1999) 0.81
Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals. Am J Med (1984) 0.81
Stimulus-specific regulation of CD63 and CD203c membrane expression in human basophils by the flavonoid quercetin. Int Immunopharmacol (2009) 0.81
Short-term neurodevelopmental outcome of babies operated on for low-risk esophageal atresia: a pilot study. Dis Esophagus (2013) 0.81
Effects on intestinal microflora, gastrointestinal tolerability and antiinflammatory efficacy of diclofenac and nitrofenac in adjuvant arthritic rats. Pharmacol Res (1994) 0.80
Copper and zinc status in rats with acute inflammation: focus on the inflamed area. Agents Actions (1988) 0.80
Effect of omeprazole on gastric acid secretion by the rat isolated stomach. Pharmacol Res Commun (1986) 0.80
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions. Eur J Clin Pharmacol (2014) 0.80
Exercise-induced coronary spasm with S-T segment depression and normal coronary arteriography. Am J Cardiol (1981) 0.80
Activity of a trinuclear platinum complex in human ovarian cancer cell lines sensitive and resistant to cisplatin: cytotoxicity and induction and gene-specific repair of DNA lesions. Br J Cancer (2001) 0.80
Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters. J Pharm Pharmacol (1983) 0.79
Clinical pharmacology of cisplatin after intraperitoneal administration in patients with malignant ascites. J Chemother (1989) 0.79
Ultrastructural hypoxic changes in Ammon's horn and Purkinje cells. Brain Res (1976) 0.79
Metabolism of arsenic after acute occupational arsine intoxication. J Toxicol Environ Health (1997) 0.79
Copper metabolism in the acute inflammatory process and its possible significance for a novel approach to the therapy of inflammation. Int J Tissue React (1985) 0.79
Subcellular reactions to injury. I. Ultrastructural and biochemical investigations on the hepatic cellular damage produced by haemorrhagic shock in dogs. J Pathol (1977) 0.79
[Pharmacokinetics of cefuroxime and cefoxitin in experimentally induced pleurisy in the rat]. G Ital Chemioter (1982) 0.79
Surgical removal of a localised vascular hepatic hamartoma in a dog. Aust Vet J (2009) 0.79
Cases of contact dermatitis caused by ultrasonographic gel. J Ultrasound Med (1998) 0.79
Intraluminal device for the protection of digestive anastomosis. Dis Colon Rectum (1996) 0.78
Effects of storage time and temperature on the concentration of ethyl carbamate and its precursors in wine. Food Addit Contam (2004) 0.78
Evaluation of the left ventricular anatomy in hypertrophic cardiomyopathy: comparison between echocardiography and cardiac magnetic resonance imaging. Minerva Cardioangiol (2008) 0.78
Copper and zinc status during acute inflammation: studies on blood, liver and kidneys metal levels in normal and inflamed rats. Agents Actions (1986) 0.78
Physical specifications of clinical proton beams from a synchrotron. Med Phys (1996) 0.78
Pathogenesis of hypertrophic cardiomyopathy. Impact of growth factors on left ventricular anatomy. Minerva Cardioangiol (2008) 0.78
Long-gap esophageal atresia: traction-growth and anastomosis - before and beyond. Dis Esophagus (2013) 0.78
Kinetics of platinum in cancer patients treated with cisplatin at different doses. Drugs Exp Clin Res (1987) 0.78
Oral zinc as initial therapy in Wilson's disease: two years of continuous treatment in a 10-year-old child. Acta Paediatr (1992) 0.77
Copper supplementation in the rat: preliminary observations on the clinical, hematological and histopathological profile. Agents Actions (1992) 0.77
Cisplatin pharmacokinetics in elderly patients. Ther Drug Monit (1994) 0.77
Pineal 5-methoxy tryptophol in man. Psychoneuroendocrinology (1979) 0.77